{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:20:38Z","timestamp":1792804838826,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J003011\/1"],"award-info":[{"award-number":["MR\/J003011\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002033"],"award-info":[{"award-number":["G1002033"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["12\/206\/52"],"award-info":[{"award-number":["12\/206\/52"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bpobgyn.2015.11.012","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T12:03:26Z","timestamp":1448453006000},"page":"54-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"special_numbering":"C","title":["Abnormal uterine bleeding"],"prefix":"10.1016","volume":"34","author":[{"given":"Lucy","family":"Whitaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary O.D.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2015.11.012_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1586\/17474108.4.2.179","article-title":"Health-related quality of life and economic burden of abnormal uterine bleeding","volume":"4","author":"Fraser","year":"2009","journal-title":"Expert Rev Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib2","first-page":"359","article-title":"An epidemiological survey of symptoms of menstrual loss in the community","volume":"54","author":"Shapley","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib3","unstructured":"NICE. Clinical Guideline 44; Heavy menstrual bleeding 2007. National Institute for Health and Clinical Excellence (NICE); Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG44FullGuideline.pdf."},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.whi.2008.07.002","article-title":"Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment","volume":"19","author":"Frick","year":"2009","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib5","series-title":"National heavy menstrual bleeding audit second annual report","author":"RCOG","year":"2012"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib6","series-title":"National heavy menstrual bleeding audit final report","author":"RCOG","year":"2014"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ogc.2005.12.011","article-title":"Future directions in myoma research","volume":"33","author":"Brahma","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib9","first-page":"CR24","article-title":"Hysterectomy surveillance in the United States, 1997 through 2005","volume":"14","author":"Merrill","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib11","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.01.001","article-title":"The FIGO classification of causes of abnormal uterine bleeding.","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib14","first-page":"736","article-title":"Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension","volume":"82","author":"Wamsteker","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11154-012-9220-x","article-title":"Classification of menstrual bleeding disorders","volume":"13","author":"Munro","year":"2012","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","article-title":"Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era","volume":"2","author":"Stewart","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1933719114533728","article-title":"Uterine fibroids: clinical manifestations and contemporary management","volume":"21","author":"Doherty","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jc.2010-1450","article-title":"Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3","volume":"96","author":"Sinclair","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1071-5576(98)00009-4","article-title":"Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium","volume":"5","author":"Palmer","year":"1998","journal-title":"J\u00a0Soc Gynecol Investig"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/09513590701557416","article-title":"Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium","volume":"23","author":"Bogusiewicz","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/aji.12127","article-title":"Cytokine patterns differ seasonally between women with and without uterine leiomyomata","volume":"70","author":"Wegienka","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/uog.6259","article-title":"Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years","volume":"33","author":"Dreisler","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2004.08.031","article-title":"Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women","volume":"83","author":"Preutthipan","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jmig.2009.04.005","article-title":"Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study","volume":"16","author":"Lieng","year":"2009","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib25","first-page":"17","article-title":"Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women","volume":"7","author":"Van den Bosch","year":"2015","journal-title":"Facts Views Vis Obgyn"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humrep\/det451","article-title":"Is adenomyosis associated with menorrhagia?","volume":"29","author":"Naftalin","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2214\/ajr.179.2.1790379","article-title":"Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease?","volume":"179","author":"Hulka","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib28","unstructured":"CRUK. Uterine Cancer Incidence Statistics: Uterine cancer incidence trends over time (last reviewed May 2014). Available at: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer\/incidence#ref-2."},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib30","doi-asserted-by":"crossref","first-page":"h4887","DOI":"10.1136\/bmj.h4887","article-title":"Fibroids: diagnosis and management","volume":"351","author":"Lumsden","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1634\/theoncologist.2014-0361","article-title":"Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma","volume":"20","author":"Brohl","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1525-1438.2007.01025.x","article-title":"The risk of developing uterine sarcoma after tamoxifen use","volume":"18","author":"Lavie","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib33","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib34","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib35","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib36","first-page":"414","article-title":"Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma","volume":"83","author":"Parker","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpobgyn.2014.04.001","article-title":"Imaging techniques in the management of abnormal vaginal bleeding in non-pregnant women before and after menopause","volume":"28","author":"Valentin","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib38","unstructured":"FDA. UPDATED Laparascopic Uterine Power Morcellation in Hysterectomy and Myomectpmy: FDA Safety Communication 2014. Available at: http:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm424443.htm."},{"issue":"Suppl. 2","key":"10.1016\/j.bpobgyn.2015.11.012_bib39","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0020-7292(12)00458-4","article-title":"FIGO Cancer Report 2012","volume":"119","author":"Denny","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","article-title":"Frequency of inherited bleeding disorders in women with menorrhagia","volume":"351","author":"Kadir","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib42","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.fertnstert.2005.05.035","article-title":"Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding","volume":"84","author":"Kouides","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0031-1287664","article-title":"Molecular and cellular causes of abnormal uterine bleeding of endometrial origin","volume":"29","author":"Critchley","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bpobgyn.2015.03.023","article-title":"The role of hysteroscopy in diagnosis of menstrual disorders","volume":"29","author":"Mahmud","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib45","article-title":"Adenomyosis; A clinical review of a challenging gynecologic condition","author":"Struble","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib46","first-page":"5","article-title":"Patients' satisfaction survey at the outpatient hysteroscopy service at St Mary's Hospital, Manchester, UK","volume":"14","author":"Maiti","year":"2008","journal-title":"Menopause Int"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib47","unstructured":"Standards for Gynaecology. RCOG; 2008: Available at: https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/wprgynstandards2008.pdf."},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib48","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","volume":"2","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib49","first-page":"CD007687","article-title":"Mifepristone for uterine fibroids","volume":"8","author":"Tristan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib50","first-page":"CD010854","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","volume":"3","author":"Moroni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib52","first-page":"CD005292","article-title":"Herbal preparations for uterine fibroids","volume":"4","author":"Liu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib53","first-page":"CD007221","article-title":"Acupuncture for uterine fibroids","author":"Zhang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib54","unstructured":"FEMME Trial; Available at: http:\/\/www.birmingham.ac.uk\/research\/activity\/mds\/trials\/bctu\/trials\/womens\/femme\/index.aspx."},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib55","doi-asserted-by":"crossref","first-page":"d2202","DOI":"10.1136\/bmj.d2202","article-title":"Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis","volume":"342","author":"Roberts","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2015.11.012_bib56","unstructured":"Problematic Bleeding with Hormonal Contraception. FSRH; 2015: Available at: http:\/\/www.fsrh.org\/pdfs\/CEUGuidanceProblematicBleedingHormonalContraception.pdf."}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T08:52:38Z","timestamp":1537174358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693415002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":56,"alternative-id":["S1521693415002266"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.012","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal uterine bleeding","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}